Continue with FacebookLooking to list your PhD opportunities? Log in here.
cancer drugs PhD Projects, Programmes & Scholarships
We have 67 cancer drugs PhD Projects, Programmes & Scholarships
PhD saved successfully
4-year PhD Studentship: Targeting cancer stem cells: Selective culture method and drug search
Cancer stem cells are a small population of cells in tumours maintaining the tumorigenic capacity (1). They are featured as quiescent (i.e., dormant), in contrast to the majority of cancer cells that actively proliferate under the aberrant regulation. Read more
Macrophage driven therapy resistance in AML: from macrophage subset characterisation to therapeutic targeting.
Research Group:
Molecular Mechanisms and Long Term Conditions
Reference. SHLS20065. Background. Acute Myeloid Leukaemia (AML) is a common blood cancer in adults; with its incidence increasing with age, AML cases are predicted to double by 2030. Read more
Breast cancer treatment and the mechanical properties of fibroblasts
In breast cancer, the amount of extracellular stroma is an indicator of poor prognosis. Read more
Cancer biology: identification of new treatment options for EML4-ALK driven lung cancer through understanding mechanisms of cell division and migration.
Lung cancer is the largest cause of cancer-related deaths in the UK and worldwide. While little progress has been made in long-term survival rates, we now have a good understanding of the genetic drivers raising the prospect of earlier diagnosis and more effective treatments. Read more
Mechanisms of resistance to anticancer drugs that define heterogeneity of cancer cell populations
Fully funded PhD study. Development of resistance to chemotherapy is a leading cause of treatment failure. Drug-resistance mechanisms typically involve mutations in specific proteins or changes in their levels of expression. Read more
School of Cancer Sciences
The School of Cancer Sciences is part of a national centre of excellence in the fight against cancer. We carry out a programme of world-class science directed at understanding the molecular changes that cause cancer. Read more
Endosomal Sorting Complex Required for Transport (ESCRT): Investigation of the role in acquired drug resistance in colon cancer
Research Group:
Institute of Cancer Therapeutics
Despite treatment advances, one of the most common cancers, colorectal cancer (CRC), still has a 45% mortality rate, and one of the major problems is the build-up of resistance to cancer drugs during treatment (‘acquired resistance’) such that over time the drugs stop working. Read more
Development of a multi-gene detection model for Chinese Luminal-type early breast cancer and its clinical translational study on the predictive value of breast cancer recurrence risk
Supervisors. Principal supervisor. Professor/Dr Jia Meng (XJTLU). Co-supervisor. Professor/Dr Xinghong Luo (JITRI). Co-supervisor. Read more
Development of bioengineered 3D tumour models for preclinical breast cancer research
UPDATE. The application of international students for this project closed 31/07/22. This is now open for AUSTRALIAN students only and will close 31/08/22. Read more
Preclinical validation of NUDT22 as target in lung cancer
We previously identified NUDT22 as an UDP-glucose hydrolase and an important new player in nucleotide and energy metabolism. Read more
The anti-cancer activity of Croton fishlockii used as a medicinal plant in traditional herbal medicines.
Within the sphere of cancer chemotherapy, many commercialised drugs have been obtained by the synthesis of new compounds, from natural sources or by structural modification of natural products. Read more
Development of novel small molecule inhibitors of Gremlin1, a pathogenic driver of diabetic kidney disease
Gremlin1 is a secreted protein antagonist of bone morphogenetic proteins (BMPs) that regulated developmental processes such as limb and kidney formation. Read more
Last chance to apply
PhD in Cancer Biology - The relationship between uptake and efflux transporters in Breast Cancer
Number of awards. 1. Start date. 19 September 2022. Award duration. 3 Year funded PhD. Overview. This PhD project will explore the role of transport proteins in Breast Cancer. Read more
On the dynamics of drug-cancer cells interactions with the aid of continuous and hybrid multiscale models
Applications are invited for a self-funded, 3-year full-time or 6-year part time PhD project. The PhD will be based in the School of Mathematics and Physics and will be supervised by. Read more
Improving survival for adult brain cancer patients by targeting ‘sleeping’ cancer stem cells.
Glioblastoma (GBM) is the most common malignant primary brain tumour in adults and is inevitably fatal, with a median survival of just 15-months after diagnosis. Read more